A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiation Therapy (SABR) Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE-NSCLC): Interim Safety Results.
Saved in:
| Title: | A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiation Therapy (SABR) Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE-NSCLC): Interim Safety Results. |
|---|---|
| Authors: | Palma, D.A.1,2, Kwan, K.3, Gaede, S.3, Landis, M.4, Malthaner, R.3, Fortin, D.3, Louie, A.V.2, Frechette, E.3, Rodrigues, G.2, Yaremko, B.5, Yu, E.1, Dar, A.R.5, Lee, T.Y.3, Gratton, A.1, Ward, A.D.6, Inculet, R.3 |
| Source: | International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pE473-E473. 1p. |
| Subjects: | Cancer treatment, Non-small-cell lung carcinoma, Stereotactic radiotherapy, Cancer radiotherapy, Cancer tomography, Computed tomography, Positron emission tomography |
| Database: | Engineering Source |
Be the first to leave a comment!
